C

CellFE - Cell Fluidics Engineering

18 employees

CellFE is a company developing a microfluidics based device to deliver gene-editing molecules.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical devices
Bioprocessing
Biotech
Gene editing
Viral vectors
mRNA
Gene therapies
Cancer therapies
Plasmid
Health Care
Cell engineering
Cell therapies
Crispr/Cas9
High throughput technology
Microfluidics

Date founded

2018

Funding rounds raised

Total raised

$22M

from 12 investors over 12 rounds

C

CellFE - Cell Fluidics Engineering raised $22M on September 27, 2023

Investors: GreatPoint Ventures, Riverine Ventures, Khosla Ventures, Embark Ventures, M Ventures, Elm Street Ventures and Cota Capital

C

CellFE - Cell Fluidics Engineering raised $4.8M on January 16, 2020

Investors: Cota Capital, Creative Destruction Lab, Elm Street Ventures and Embark Ventures

C

CellFE - Cell Fluidics Engineering raised undisclosed on September 1, 2018

Investors: Berkeley SkyDeck

FAQ